SEC Form 4 · accession 0001562180-16-002546
Ultragenyx Pharmaceutical Inc. · RARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Richard Pinion
Officer — See Remarks
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515673
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $69.53 | Jun 3, 2016 | A | 11,000 | A | — | Jun 3, 2026 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Remarks
SVP and Chief Quality Operations Officer